Transamerica Financial Advisors Inc. boosted its stake in shares of Fabrinet (NYSE:FN – Free Report) by 17.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 565 shares of the technology company’s stock after purchasing an additional 83 shares during the period. Transamerica Financial Advisors Inc.’s holdings in Fabrinet were worth $125,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the stock. Barclays PLC grew its holdings in shares of Fabrinet by 304.6% during the 3rd quarter. Barclays PLC now owns 69,128 shares of the technology company’s stock valued at $16,345,000 after acquiring an additional 52,042 shares in the last quarter. Salem Investment Counselors Inc. purchased a new position in Fabrinet in the fourth quarter valued at about $518,000. Janney Montgomery Scott LLC increased its position in Fabrinet by 2.6% in the 4th quarter. Janney Montgomery Scott LLC now owns 3,279 shares of the technology company’s stock worth $721,000 after purchasing an additional 82 shares during the last quarter. Citigroup Inc. raised its stake in shares of Fabrinet by 13.9% during the 3rd quarter. Citigroup Inc. now owns 38,115 shares of the technology company’s stock worth $9,012,000 after purchasing an additional 4,639 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Fabrinet by 3.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 660,401 shares of the technology company’s stock valued at $156,145,000 after buying an additional 24,439 shares during the last quarter. Institutional investors and hedge funds own 97.38% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on FN. Barclays dropped their price objective on Fabrinet from $292.00 to $245.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 4th. Needham & Company LLC restated a “buy” rating and set a $280.00 price target on shares of Fabrinet in a research note on Monday, March 17th. JPMorgan Chase & Co. reduced their price objective on shares of Fabrinet from $275.00 to $265.00 and set a “neutral” rating for the company in a research note on Tuesday, February 4th. Rosenblatt Securities reiterated a “buy” rating and issued a $285.00 price objective on shares of Fabrinet in a report on Friday, March 14th. Finally, Fox Advisors assumed coverage on Fabrinet in a report on Tuesday, February 18th. They set an “overweight” rating and a $270.00 target price on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, Fabrinet has an average rating of “Hold” and an average target price of $250.43.
Fabrinet Price Performance
Shares of FN opened at $195.58 on Friday. Fabrinet has a one year low of $159.69 and a one year high of $281.79. The company’s fifty day moving average price is $216.64 and its 200 day moving average price is $230.21. The company has a market capitalization of $7.09 billion, a PE ratio of 21.88 and a beta of 0.89.
Fabrinet (NYSE:FN – Get Free Report) last announced its earnings results on Monday, February 3rd. The technology company reported $2.38 earnings per share for the quarter, missing the consensus estimate of $2.48 by ($0.10). Fabrinet had a net margin of 10.44% and a return on equity of 18.48%. Analysts anticipate that Fabrinet will post 9.4 earnings per share for the current year.
Fabrinet Profile
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Further Reading
- Five stocks we like better than Fabrinet
- Golden Cross Stocks: Pattern, Examples and Charts
- MarketBeat Week in Review – 03/24 – 03/28
- What is MarketRank™? How to Use it
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- The Significance of Brokerage Rankings in Stock Selection
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.